P

Peters Medical Research | High Point, NC

Research site

(Unclaimed)

Location

665 North Main Street, High Point, North Carolina, United States of America

Site insights

Top conditions

Top treatments

Lubiprostone

Diclofenac

Oxycodone

Vibegron

PRC-4016

CIN-102

Vonoprazan

Naproxen

Famciclovir

Dapsone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 64 total trials

A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (ASTRO)

The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in...

Active, not recruiting

Colitis, Ulcerative

Drug: Guselkumab Dose 2

Other: Placebo

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopa...

Enrolling

Idiopathic Gastroparesis

Drug: Placebo

Drug: CIN-102 Dose 15mg

New

Confirmatory Clinical Study in Active Ulcerative Colitis (StarFish-UC)

The main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcerative Colitis, MH002 was found...

Begins enrollment in 2 months

Colitis, Ulcerative

Drug: High-dose MH002

Drug: Placebo

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine